NDC 80425-0465-01 - LORAZEPAM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0465
- Requested NDC
- 80425-0465-01
- Package NDCs from labels
- 80425-0465-2, 80425-0465-1, 80425-0465-3, 80425-0465-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2024-12-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LORAZEPAM - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2024-12-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0465-1 | LORAZEPAM | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 80425-0465-2 | LORAZEPAM | 60 in 1 BOTTLE | TABLET | 60 | 1 | |
| 80425-0465-3 | LORAZEPAM | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0465 | LORAZEPAM TABLET [ADVANCED RX OF TENNESSEE, LLC] | 1 | Current NDC, 3 package rows | 20241229_2a57e549-390b-5482-e063-6394a90aeb3b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0465-1 | EA - Each | 80425-0465 | c9a5c15d-634e-4151-9f9d-ac45e6e2ff55 | 1 | 2025-02-10 |
| 80425-0465-2 | EA - Each | 80425-0465 | f1a7c740-4286-4317-b809-d7bdd589bada | 1 | 2025-02-10 |
| 80425-0465-3 | EA - Each | 80425-0465 | d0a1df18-ba50-4e23-81b5-85ef0801a801 | 1 | 2025-02-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Rising Pharma Holdings, Inc. | 386255e2-65aa-48ce-9eb1-246f1493cc14 | 2025-07-29 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | Preferred Pharmaceuticals, Inc. | 00960fbd-a5da-408b-9867-62982f20906f | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | ANDA203572 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | Preferred Pharmaceuticals, Inc. | 6cc1f35d-ff33-404e-aa5e-b01eab89863e | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | ANDA203572 197902 O26FZP769L |
| Ativan | LORAZEPAM | Bausch Health US LLC | 89057c93-8155-4040-acec-64e877bd2b4c | 2025-07-09 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
| LOREEV XR | LORAZEPAM | A-S Medication Solutions | c470fdee-8e18-4da9-b072-943d6b2518cf | 2025-07-03 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 3c20c89f-c8c3-43b3-837e-da413f449795 | 2025-05-27 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 17919c82-87f2-5030-e063-6294a90ac91a | 2025-04-21 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | Golden State Medical Supply, Inc. | 32fb5628-bf80-0135-e063-6294a90aa3ab | 2025-04-17 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 1791d5c9-9004-5c4b-e063-6294a90adf3d | 2025-04-08 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 8aaf9bcb-7a4e-ffaa-e053-2995a90a3913 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | ANDA203572 197901 O26FZP769L |
| LORAZEPAM | LORAZEPAM | DirectRx | ddcc0b2b-4be2-6d18-e053-2a95a90af987 | 2025-01-22 | Warnings, Adverse reactions | ANDA203572 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 4a66b854-4dd6-3746-e054-00144ff8d46c | 2025-01-20 | Warnings, Adverse reactions | 197900 O26FZP769L |
| LORAZEPAM | LORAZEPAM | Advanced Rx of Tennessee, LLC | 2a57e549-390b-5482-e063-6394a90aeb3b | 2024-12-28 | Boxed warning, Warnings, Adverse reactions | ANDA203572 80425-0465-2 80425-0465-1 80425-0465-3 80425-0465 80425046501 197901 2a57e551-1ed3-718f-e063-6394a90a30e1 2a57e549-390b-5482-e063-6394a90aeb3b O26FZP769L |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 29f63525-2839-946c-e063-6294a90aebb1 | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | Fresenius Kabi USA, LLC | b2487467-a63f-48b5-b0de-3a6ce6672d50 | 2024-11-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 503834f9-fa2e-5e23-e054-00144ff88e88 | 2024-11-13 | Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | A-S Medication Solutions | be85b116-9f09-403a-8e0d-e77e344d3a9a | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | Chartwell RX, LLC | 6b0619c5-b9e9-47e7-97b5-7e581e67cf5f | 2024-11-07 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | Asclemed USA, Inc. | ebdf72f7-7462-4b83-81b4-c7988860c728 | 2024-11-05 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.